Methyl Jasmonate: Behavioral and Molecular Implications in Neurological Disorders
10.9758/cpn.2021.19.2.220
- Author:
Oritoke Modupe ALUKO
1
;
Joy Dubem IROEGBU
;
Omamuyovwi Meashack IJOMONE
;
Solomon UMUKORO
Author Information
1. Department of Physiology, Federal University of Technology, Akure, Nigeria
- Publication Type:Review
- From:Clinical Psychopharmacology and Neuroscience
2021;19(2):220-232
- CountryRepublic of Korea
- Language:English
-
Abstract:
Methyl jasmonate (MJ) is a derivative of the jasmonate family which is found in most tropical regions of the world and present in many fruits and vegetables such as grapevines, tomato, rice, and sugarcane. MJ is a cyclopentanone phytohormone that plays a vital role in defense against stress and pathogens in plants. This has led to its isolation from plants for studies in animals. Many of these studies have been carried out to evaluate its therapeutic effects on behavioral and neurochemical functions. It has however been proposed to have beneficial potential over a wide range of neurological disorders. Hence, this review aims to provide an overview of the neuroprotective properties of MJ and its probable mechanisms of ameliorating neurological disorders. The information used for this review was sourced from research articles and scientific databases using ‘methyl jasmonate’, ‘behavior’, ‘neuroprotection’, ‘neurodegenerative diseases’, and ‘mechanisms’ as search words. The review highlights its influences on behavioral patterns of anxiety, aggression, depression, memory, psychotic, and stress. The molecular mechanisms such as modulation of the antioxidant defense, inflammatory biomarkers, neurotransmitter regulation, and neuronal regeneration, underlying its actions in managing neurodegenerative diseases like Alzheimer’s and Parkinson’s diseases are also discussed. This review, therefore, provides a detailed evaluation of methyl jasmonate as a potential neuroprotective compound with the ability to modify behavioral and molecular biomarkers underlying neurological disorders. Hence, MJ could be modeled as a guided treatment for the management of brain diseases.
